Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Ital J Pediatr ; 50(1): 101, 2024 May 18.
Artigo em Inglês | MEDLINE | ID: mdl-38762477

RESUMO

BACKGROUND: Sepsis is one of the main causes of death in newborns worldwide. Vitamin D levels during fetal and neonatal periods have a significant role in the development of the immunological system. The study aims to evaluate the association between vitamin D levels and the risk of early-onset neonatal sepsis in full-term neonates in a developing country. METHODS: This case-control study was conducted at the Neonatal Intensive Care Units (NICUs) of Kasr Alainy Hospital, Cairo, Egypt. The study was composed of two groups; the sepsis group involved full-term neonates appropriate for gestational age with sepsis-related clinical signs. The control group included newborns with no signs of clinical/laboratory infection within 72 h of life. Blood samples were collected on admission during the first three days of life in both groups for the measurement of 25-hydroxyvitamin D levels, Complete Blood Count (CBC), C reactive protein (CRP), and blood culture. RESULTS: Forty-five newborns with clinical and laboratory findings of early-onset neonatal sepsis within 72 h of life were enrolled, and the control group included forty-five newborns with no evidence of sepsis. Vitamin D levels in the sepsis group were significantly lower than in the control group. Apgar score at the first minute was significantly lower in the sepsis group. 57.8% of neonates with sepsis had positive blood cultures. There was a statistical difference between deficient, insufficient, and sufficient vitamin D levels regarding the duration of the NICU stay, which was longer in neonates with deficient vitamin D levels. CRP was significantly higher in neonates with deficient vitamin D levels. The area under the receiver operating characteristic curve for serum vitamin D in the prediction of neonatal sepsis was 0.76 at a cutoff < 19.7(ng/ml). CONCLUSION: In the current study, full-term newborns with EOS had considerably lower vitamin D levels than healthy controls. Through appropriate vitamin supplementation of the mothers during pregnancy, it could be possible to ensure adequate vitamin D levels for newborns. This may contribute to the reduction of the risk of EOS, together with the other well-known preventive measures (i.e. breastfeeding and intrapartum antibiotic prophylaxis).


Assuntos
Sepse Neonatal , Deficiência de Vitamina D , Vitamina D , Humanos , Recém-Nascido , Estudos de Casos e Controles , Sepse Neonatal/sangue , Sepse Neonatal/diagnóstico , Feminino , Masculino , Egito/epidemiologia , Deficiência de Vitamina D/sangue , Deficiência de Vitamina D/epidemiologia , Deficiência de Vitamina D/complicações , Vitamina D/sangue , Vitamina D/análogos & derivados , Unidades de Terapia Intensiva Neonatal , Fatores de Risco , Proteína C-Reativa/análise , Proteína C-Reativa/metabolismo
2.
J Allergy Clin Immunol Pract ; 11(1): 158-180.e11, 2023 01.
Artigo em Inglês | MEDLINE | ID: mdl-36265766

RESUMO

Human inborn errors of immunity (IEI) are a group of 485 distinct genetic disorders affecting children and adults. Signs and symptoms of IEI are heterogeneous, and accurate diagnosis can be challenging and depends on the available human expertise and laboratory resources. The Middle East and North Africa (MENA) region has an increased prevalence of IEI because of the high rate of consanguinity with a predominance of autosomal recessive disorders. This area also exhibits more severe disease phenotypes compared with other regions, probably due to the delay in diagnosis. The MENA-IEI registry network has designed protocols and guidelines for the diagnosis and treatment of IEI, taking into consideration the variable regional expertise and resources. These guidelines are primarily meant to improve the care of patients within the region, but can also be followed in other regions with similar patient populations.


Assuntos
Consanguinidade , Adulto , Criança , Humanos , África do Norte/epidemiologia , Oriente Médio/epidemiologia , Fenótipo , Sistema de Registros
5.
BMC Res Notes ; 11(1): 717, 2018 Oct 11.
Artigo em Inglês | MEDLINE | ID: mdl-30305145

RESUMO

OBJECTIVE: Primary immunodeficiency (PID) patients are prone to developing viral infections and should not be vaccinated with live vaccines. In such patients, prolonged excretion and viral divergence may occur and they may subsequently act as reservoirs in the community introducing mutated virus and jeopardizing polio eradication. One hundred and thirty PID cases were included for poliovirus detection in stool with assessment of divergence of detected polioviruses from oral polio vaccine (OPV) virus. Clinical presentations of PID patients with detectable poliovirus in stool specimens are described. RESULTS: Six PID patients (4.5%) had detectable vaccine-derived poliovirus (VDPV) excretion in stool specimens; of these, five patients had severe combined immunodeficiency (two with acute flaccid paralysis, one with meningoencephalitis and two without neurological manifestations), and one patient had X-linked agammaglobulinemia (paralysis developed shortly after diagnosis of immunodeficiency). All six case-patients received trivalent OPV. Five case-patients had type 2 immunodeficiency-related vaccine-derived polioviruses (iVDPV2) excretion; one had concomitant excretion of Sabin like type 3 virus and one was identified as iVDPV1 excretor. Surveillance for poliovirus excretion among PID patients is critical as these patients represent a potential source to reseed polioviruses into populations.


Assuntos
Portador Sadio/virologia , Síndromes de Imunodeficiência/virologia , Poliomielite/transmissão , Vacina Antipólio Oral/efeitos adversos , Vacinação/efeitos adversos , Eliminação de Partículas Virais , Portador Sadio/imunologia , Portador Sadio/patologia , Erradicação de Doenças , Egito/epidemiologia , Fezes/virologia , Feminino , Humanos , Síndromes de Imunodeficiência/epidemiologia , Síndromes de Imunodeficiência/imunologia , Síndromes de Imunodeficiência/mortalidade , Lactente , Masculino , Poliomielite/epidemiologia , Poliomielite/imunologia , Poliomielite/prevenção & controle , Poliovirus/imunologia , Poliovirus/patogenicidade , Vacina Antipólio Oral/administração & dosagem , Vigilância em Saúde Pública
6.
J Clin Immunol ; 36(7): 649-55, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-27484503

RESUMO

INTRODUCTION: Primary immunodeficiency disorders (PIDs) are heterogeneous disorders that mainly present with severe, persistent, unusual, or recurrent infections in childhood. Reports from different parts of the world indicate a difference between Western and Eastern populations. AIM: The aim of this study was to report on the different patterns of PIDs and identify subgroup characteristics in a highly consanguineous population in Egypt. METHODS: We performed a retrospective chart review for children below 18 years diagnosed with PID at Cairo University Pediatric Hospital from 2010 to 2014. RESULTS: Four hundred seventy-six children were diagnosed with PID disorders. Major categories included combined immunodeficiency disorders, which constituted a large proportion (30 %) of cases, along with predominantly antibody disorders (18 %) followed by syndromic combined disorders (16.8 %), phagocytic disorders (13.2 %), immune dysregulation disorders (10.5 %), and autoinflammatory disorders (9 %). CONCLUSION: PIDs have different patterns within inbred populations with high consanguinity.


Assuntos
Consanguinidade , Síndromes de Imunodeficiência/diagnóstico , Síndromes de Imunodeficiência/genética , Fenótipo , Idade de Início , Criança , Pré-Escolar , Diagnóstico Tardio , Egito/epidemiologia , Feminino , Estudos de Associação Genética , Heterogeneidade Genética , Predisposição Genética para Doença , Testes Genéticos/métodos , Hospitais Universitários , Humanos , Síndromes de Imunodeficiência/epidemiologia , Masculino , Programas de Rastreamento , Vigilância da População , Sistema de Registros , Estudos Retrospectivos
7.
Neuropediatrics ; 47(3): 151-6, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-27064330

RESUMO

Introduction Guillain-Barré syndrome (GBS) is an autoimmune peripheral neuropathy characterized by demyelination and axonal damage. Biallelic functional polymorphisms in the immunoglobulin G Fc receptors (FcγR)-FcγRIIA: H131/R131, FcγRIIIA: V158/F158, and FcγRIIIB: NA1/NA2 affect the affinity of the IgG-FcγR interaction, therefore, diseases such as GBS in which this interaction plays a critical role might be influenced by the polymorphisms. Methods We evaluated the role of FcγR polymorphisms in susceptibility to GBS in Egyptian pediatric patients and the association of the variant alleles with neurophysiological types, severity, and outcome of the disease. A total of 50 patients with GBS and 50 controls were examined for FcγR polymorphisms by allele-specific polymerase chain reaction. Results FcγRIIA H131 allele (p = < 0.0001; odds ratio [OR] = 4.78; 95% confidence interval [CI], 2.62-8.70) and FcγRIIA H/H131 genotype (p = < 0.0001 ; OR = 10.56; 95% CI, 3.59-31.06) were significantly increased in GBS patients while FcγRIIIA and FcγRIIIB allelic distributions were similar among patients and controls. The FcγR genotypes showed no association with neurophysiological types of GBS, severity or outcome of the disease. Conclusions These findings reflect that FcγRIIA H131 allele may represent a risk marker for susceptibility to GBS.


Assuntos
Síndrome de Guillain-Barré/genética , Receptores de IgG/genética , Alelos , Estudos de Casos e Controles , Criança , Pré-Escolar , Feminino , Proteínas Ligadas por GPI/genética , Frequência do Gene , Predisposição Genética para Doença , Genótipo , Humanos , Lactente , Masculino , Reação em Cadeia da Polimerase , Polimorfismo Genético
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA